首页> 外国专利> abuse-resistant melt-extruded formulation with reduced alcohol interaction.

abuse-resistant melt-extruded formulation with reduced alcohol interaction.

机译:减少酒精相互作用的抗滥用熔融挤出配方。

摘要

The present invention relates to compositions for oral administration. The invention preferably comprises at least one abuse-resistant drug delivery composition for delivering a drug having potential for dose dumping in alcohol, related methods of preparing these dosage forms, and methods of treating a patient in need thereof comprising administering the inventive compositions to the patient. Most preferably, the dosage form includes verapamil. These formulations have reduced potential for abuse. In another formulation, preferably the abuse relevant drug is an opioid and the non-abuse relevant drug is acetaminophen or ibuprofen. More preferably, the opioid is hydrocodone, and the non-abuse relevant analgesic is acetaminophen. In certain preferred embodiments, the dosage forms are characterized by resistance to solvent extraction; tampering, crushing or grinding. Certain embodiments of the inventions provide dosage forms that provide an initial burst of release of drug followed by a prolonged period of controllable drug release.
机译:本发明涉及用于口服的组合物。本发明优选地包括至少一种用于递送具有可能在酒精中倾倒剂量的药物的抗滥用药物递送组合物,制备这些剂型的相关方法以及治疗需要其的患者的方法,包括向患者施用本发明的组合物。 。最优选地,剂型包括维拉帕米。这些配方降低了滥用的可能性。在另一种制剂中,优选与滥用有关的药物是阿片类药物,与非滥用有关的药物是对乙酰氨基酚或布洛芬。更优选地,阿片样物质是氢可酮,并且非滥用相关的镇痛药是对乙酰氨基酚。在某些优选的实施方案中,所述剂型的特征在于对溶剂萃取的抗性;优选地,所述剂型具有抗溶剂性。篡改,压碎或研磨。本发明的某些实施方案提供了剂型,其提供了药物释放的初始爆发,随后是可控药物释放的延长时间。

著录项

  • 公开/公告号BRPI0924036A2

    专利类型

  • 公开/公告日2019-09-24

    原文格式PDF

  • 申请/专利权人 ABBOTT GMBH & CO. KG;

    申请/专利号BR2009PI24036

  • 申请日2009-05-26

  • 分类号A61K31/485;A61K9/20;A61K31/167;A61K31/277;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号